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Abstract We determined the extent to which diurnal varia-
tion in cholesterol synthesis in liver is controlled by steady-
state mRNA levels for the rate-limiting enzyme in the pathway,
hydroxymethylglutaryl (HMG)-CoA reductase. Rats 30 days
of age and maintained on a low-cholesterol diet since weaning








O. The specific radio-
activity of the whole-body water pool soon became constant,
allowing for expression of values for incorporation of label
into cholesterol as absolute rates of cholesterol synthesis. In










noon. Increases in synthesis were quantitatively in lock step
with increases in mRNA levels for HMG-CoA reductase occur-
ring 4 h earlier. In a parallel experiment, rats received 1%
cholesterol in the diet from weaning to 30 days of age. Basal
levels of hepatic cholesterol synthesis were greatly diminished
and there was little diurnal variation of cholesterol synthesis
or of levels of mRNA for HMG-CoA reductase. Levels of
mRNA for the low density lipoprotein receptor and scavenger
receptor-B1 (putative high density lipoprotein receptor)
showed little diurnal variation, regardless of diet. This sug-
gests that diurnal variation of hepatic cholesterol synthesis is
driven primarily by varying the steady-state mRNA levels for
HMG-CoA reductase. Other tissues were also examined. Ad-
renal gland also showed a 4-fold diurnal increase in accumula-
tion of recently synthesized cholesterol. In contrast to liver,
however, there was little corresponding change in mRNA ex-
pression for HMG-CoA reductase. Much of this newly synthe-
sized cholesterol may be of hepatic origin, imported into ad-
renal by SR-B1, whose mRNA was up-regulated 2-fold. In
brain, there was no diurnal variation in either cholesterol syn-
thesis or mRNA expression, and no influence of high- or low-
cholesterol diets on synthesis rates or HMG-CoA reductase
mRNA levels.
 
—Jurevics, H., J. Hostettler, C. Barrett, P. Morell,
and A. D. Toews.
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The existence of a circadian rhythm for hepatic choles-
terol biosynthesis is well established (1–5). It is also
known that cholesterol synthesis is suppressed by dietary
cholesterol (6–8). Much of this metabolic control is ex-
erted at the level of hydroxymethylglutaryl (HMG)-CoA
reductase activity, a rate-limiting enzyme in the pathway
for cholesterol synthesis (see ref. 9). Elucidation of quan-
titative aspects of this relationship is complicated by diffi-
culties in obtaining absolute rates of cholesterol synthesis
in vivo, as commonly used radioactive precursors are di-
luted to unknown extents in different body compartments.








O such as those by
Edwards, Muroya, and Gould (10) and Jeske and Dietschy
(11).
Although HMG-CoA reductase activity can be manipu-
lated in cultured cells, questions arise as to the relative
roles of the different control mechanisms in vivo in set-
ting the hepatic circadian rhythm for cholesterol produc-
tion, and in effecting dietary regulation of cholesterol bio-
synthesis. HMG-CoA reductase activity is set by steady-state
levels of mRNA, as well as by various post-translational
mechanisms. The latter include protein synthesis and deg-
radation, as well as balance between cAMP-dependent
kinase phosphorylation (inactivation) and phosphatase-
catalyzed dephosphorylation of the enzyme (for review,
see ref. 12). Specifically, we wished to know the relative roles
of steady-state mRNA levels versus that of post-translational
mechanisms with respect to control of cholesterol biosyn-
thesis. Our experimental design involved correlating rates
of cholesterol synthesis with levels of mRNA for HMG-
CoA reductase in various tissues over the course of 24 h in
animals on either a low-cholesterol or high-cholesterol
diet (because of the possible interplay of circadian rhythm
and nutritional status). Cholesterol synthesis rates were
determined in vivo; eliminating the possibility that assay
of cholesterol synthesis ex vivo does not truly reflect in
vivo activity. Our results suggest that much of the variation
 
Abbreviations: HMG, hydroxymethylglutaryl; SR, scavenger receptor;
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in hepatic cholesterol synthesis, both with respect to diur-
nal variation and as a function of cholesterol in the diet, is
set by regulation of the steady state level of mRNA. Rele-
vant to interpretation of these data, we assayed mRNA levels
for two lipoproteins involved in cholesterol trafficking,
the low density lipoprotein receptor (LDL-R) and the
scavenger receptor B1 (SR-B1; putative HDL-receptor). As
a control for organ specific aspects of the relationship be-
tween circadian rhythm and cholesterol biosynthesis, we
also examined these parameters in brain and adrenal





Male Sprague-Dawley rats were either obtained from our own
breeding colony or from Charles River Breeding Laboratories
(Raleigh, NC). Animals were maintained on a 12-h light/dark








) and retrieved from the animal facil-
ity 1 h before each designated time point (light or dark condi-
tions were maintained during transport and subsequent labeling
periods; see below). To assess the rate of cholesterol synthesis,









tained for a 2-h labeling period that bracketed each time point
(injection 1 h prior to, and killing 1 h after, each plotted time
point). Rats were killed every 4 h, beginning with the 12 noon
time point. Liver, adrenal glands, and brain were dissected,
weighed, and lipids were extracted. Blood samples were also ob-
tained and used to prepare serum for determination of specific









serum). For RNA analysis, tissue samples from parallel groups
of animals of the same ages and dietary conditions as described









C prior to analysis. The animals studied were from
litters weaned at 20 days of age onto either a low-cholesterol diet




0.002% cholesterol as re-
ported at www.labdiet.com) or a high-cholesterol diet (milled









St. Louis, MO). The investigation of diurnal cycle was initiated at
noon when the animals were 30 days of age. A similar experi-
ment was also carried out with suckling animals, 16 days of age,
except without the variable of diet.
 
Lipid extraction and separation
 
Lipids were extracted by a modification (13) of the method of
Folch, Lees, and Sloane Stanley (14). Sterols were separated from
other lipids by reverse-phase HPLC on a C18 column and were
eluted isocratically with acetonitrile–isopropanol (97.5:2.5). Ab-
sorbance of the eluate was monitored at 210 nm to determine
fractions containing cholesterol, desmosterol (a significantly la-
beled cholesterol precursor in brain), and lanosterol (a signifi-
cantly labeled cholesterol precursor in liver). Radioactivity in
eluted fractions corresponding to the various lipids was deter-
mined by evaporating the samples, adding scintillation fluid, and
quantitating radioactivity in a liquid scintillation counter.
 
Assay of cholesterol biosynthesis
 
Methods for determination of cholesterol synthesis were as
outlined in detail previously (15, 16). Briefly, the rate of choles-
terol synthesis was determined by measurement of incorpora-








O into HPLC peaks cor-
responding to cholesterol (and desmosterol and lanosterol,
precursors committed to this biosynthetic pathway). The under-








O equilibrates with all body pools of
water. Newly synthesized cholesterol incorporates hydrogen
from water with a stoichiometry in accordance with the known
pathway for cholesterol biosynthesis. As reviewed by Dietschy
and Spady (17), 22 hydrogens, either from water directly or
from metabolic intermediates whose protons rapidly equilibrate
with water, are incorporated into cholesterol. Thus, the amount
of cholesterol synthesized during the labeling period can be cal-
culated from radioactivity present in cholesterol (and related
precursors), assuming the specific radioactivity of newly synthe-
sized cholesterol is 11 times that of the body pool of water. The
smaller amounts of labeled desmosterol and lanosterol, presum-
ably committed to cholesterol biosynthesis, were accounted for
by assuming specific radioactivities of 10 and 9 times, respec-
tively, that of body water. Relevant to the present study was the
presence of label in liver lanosterol which, depending on condi-
tions, accounted for 2 to 26% of the total label in sterol at 2 h








O. Label in adrenal lanosterol stayed more
constant, about 6% under all conditions studied. The fraction of
total sterol label present as desmosterol in brain was about 60%
under a variety of conditions, as reported previously (16).
If the incorporation of label were to be interpreted as a rate in
absolute terms, it would be necessary to correct for the time-lag
before the rate of incorporation of label into sterols (cholesterol
and major lipid precursors) became linear with time. This time-
lag accounts for equilibration of label from injected water with
the body pool of water and subsequent early steps of incorpora-
tion leading to sterol biosynthesis. Determination of this time-lag
is possible and, for example, for various brain regions it varies
from 15 to 20 minutes (16). It was not feasible, however, to deter-
mine a time-lag for liver as the diurnal cycle introduces differ-
ences in incorporation rate within the same time frame as re-
quired to determine whether incorporation of label was linear.
Thus, we report the data directly as assayed, without accounting
for the time-lag. We reasoned that only the most drastic changes
between tissues, as regards time-lag for equilibration of label
with precursors, would significantly alter the relative values of
rates of synthesis as measured during the diurnal cycle.
 
Assay of mRNA species
 
Procedures for analysis of mRNA have been described in detail
previously (18). Briefly, total RNA was isolated from frozen tissues
by homogenization in guanidine isothiocyanate followed by cen-
trifugation through cesium chloride with subsequent ethanol
precipitation (19). RNA species were separated according to mo-
lecular weight on denaturing 0.8% agarose gels containing form-
aldehyde and then transferred to Zeta-Probe nylon blotting





P-labeled cDNA probes specific for HMG-CoA
reductase (20), LDL-receptor (21), or SR-B1 (22), all synthesized
using single-stranded polymerase chain reaction methodology
(23). Filters were washed and distribution of RNA was quanti-
tated using a Packard InstantImager electronic autoradiography
system. Filters were also exposed to X-ray film to obtain a visual
pattern of mRNA levels. To control for variability in sample han-
dling, values obtained were normalized to the amount of riboso-









Synthesis of hepatic cholesterol as a function 
of diurnal cycle and dietary cholesterol
 
Incorporation of label from tritiated water into choles-
terol (and its precursor, lanosterol) was monitored as a di-
 




rect correlate of the absolute rate of cholesterol synthesis
in vivo. When young adult rats were fed a low-cholesterol
diet, there was a 4-fold elevation in the rate of cholesterol





). When rats were maintained on a diet contain-
ing 1% cholesterol, the basal level of cholesterol biosyn-
thesis was lowered by 60–70% and diurnal variation was sup-
pressed. When suckling rats were examined, there was little
diurnal variation in cholesterol biosynthesis, and choles-
terol synthesis was even more suppressed, presumably re-
flecting down-regulation by the high cholesterol content
of dam’s milk.
For animals on a low-cholesterol diet, the steady-state
level of mRNA for HMG-CoA reductase tracked cholesterol
synthesis reasonably well, with the observed up-regulation
of mRNA levels preceding the increase in synthesis by 4–6
hours (Fig. 1B). This is of interest because the peak mRNA
level occurred prior to initiation of the dark period and
the consequent marked increase in feeding activity. Up-
regulation of HMG-CoA mRNA was severely blunted in
animals fed a high-cholesterol diet and was absent in the
milk-fed suckling pups. As cholesterol levels in liver are in-
fluenced by uptake of cholesterol-containing lipoproteins
from the circulation as well as by de novo synthesis, we
also assayed mRNA levels for two lipoprotein receptors,
LDL-R (Fig. 1C) and SR-B1 (Fig. 1D). There were no no-
ticeable diurnal variations in mRNA levels for either of
these two lipoprotein receptors.
 
Synthesis of brain cholesterol as a function
of diurnal cycle and dietary cholesterol
 
Our data give no evidence for diurnal variation in cho-





). Cholesterol synthesis in brains of the 16-day-
old suckling animals was approximately 50% higher than
that in the 30-day-old rats; this presumably reflects the rapid
accumulation of cholesterol-rich myelin in the younger ani-
mals. As circulating cholesterol is not available for use by
the nervous system, all cholesterol required for myelin must
be synthesized locally in brain (16, 24). There was also no
significant diurnal variation in brain for mRNA levels cod-
ing for HMG-CoA reductase (Fig. 2B) or for the two lipo-
protein receptors studied (Fig. 2C, D). In addition, dietary
status had no effect on mRNA levels for these proteins.
 
Synthesis of adrenal cholesterol as a function 
of diurnal cycle and dietary cholesterol
 
For animals on a low cholesterol diet, the diurnal varia-
tion in cholesterol biosynthesis in the adrenal gland was




). In contrast to liver,
however, the prominent increase in cholesterol synthesis
in the middle of the dark phase was not preceded by an
increase in HMG-CoA reductase mRNA levels (Fig. 3B).
Inclusion of cholesterol in the diet markedly suppressed
basal levels of cholesterol synthesis as well as the diurnal
increase, again without observable fluctuation in levels of
mRNA for HMG-CoA reductase. Interestingly, although
neither diet or cholesterol feeding status had much effect
on LDL-R mRNA levels, there was an approximately 2-fold
Fig. 1. (A) Diurnal variation of rates of cholesterol synthesis in liv-
ers of 30-day-old rats. Animals were kept on either a low-cholesterol
diet or on a 1% cholesterol diet for 10 days after weaning. Data for
16-day-old suckling pups are also shown. Absolute in vivo synthesis
rates of cholesterol were determined after intraperitoneal injection
of 3H2O. The assay involved determination of radioactivity incorpo-
rated into HPLC peaks corresponding to cholesterol as well as label
in precursors committed to the cholesterol biosynthesis pathway (see
Methods for details). (B) Diurnal variation in steady-state level of
mRNA for HMG-CoA reductase in liver. Northern blots were carried
out with a 32P-labeled cDNA probe specific for HMG-CoA reductase,
as described in Methods. After rinsing to remove unbound probe, fil-
ters were exposed to X-ray film to obtain a visual image of relative
mRNA levels. Typical results are shown in the insert. Data such as
that shown in the insert were quantified using an electronic autorad-
iography system, and the results were plotted. Data have been nor-
malized to a constant amount of rRNA, as assessed after hybridiza-
tion with 32P end-labeled oligonucleotides specific for 28S rRNA.
Values are means 6 SEM of 3 different samples, except that those for
suckling animals were obtained with single samples. (C) Diurnal vari-
ation in steady-state level of mRNA for LDL-receptor in liver. Other-
wise as in legend to 1B. (D) Diurnal variation in steady-state level of
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diurnal increase in mRNA levels for SR-B1, and this in-
crease was present in animals on both the low- or high-
cholesterol diets (Fig. 3C, D); see Discussion regarding a
role for this receptor in uptake of circulating cholesterol
by adrenal gland. Levels of synthesis of cholesterol by ad-
renal gland in suckling pups was very low, presumably due
to the presence of maternally derived hormones that sup-
press growth and maturation of the adrenals (25).
 
Relative levels of mRNA expression in liver, 
brain and adrenal glands
 
A comparison of relative levels of mRNA for HMG-CoA
reductase, LDL-R, and SR-B1 in various tissues of 30-day-




 (time of maximal





 For each of the three mRNA species ex-
amined, levels were highest in adrenal gland. Levels of
mRNA for HMG-CoA reductase in liver and brain were ap-
proximately 60% and 25% of those in adrenal, respec-
tively. For both LDL-R and SR-B1, mRNA levels in liver
and brain were much lower than in adrenal gland.
DISCUSSION
The diurnal 4-fold variation in hepatic cholesterol syn-
thesis is similar to that reported previously (10, 26, 27).
Our data correlating this variation with that for mRNA lev-
els for HMG-CoA reductase suggest that much of the con-
trol for activity of this rate-limiting enzyme of cholesterol
biosynthesis involves alterations in steady-state mRNA lev-
els. Dietary cholesterol clearly suppresses the dark-phase ele-
vation of cholesterol synthesis and the preceding rise in
HMG-CoA reductase mRNA. We conclude that the increased
hepatic synthesis of cholesterol in rats fed cholesterol-poor
diets, relative to those on cholesterol-rich diets, is driven
Fig. 2. Diurnal variation of rate of cholesterol synthesis, and of
mRNA levels, in brains of the same rats described in the legend to
Fig.1. All sections of that legend apply with the substitution of
“brain” for “liver.”
Fig. 3. Diurnal variation of rate of cholesterol synthesis, and of
mRNA levels, in adrenal glands of the same rats described in the
legend to Fig. 1. All sections of that legend apply with the substitu-
tion of “adrenal gland” for “liver.”
 




largely by increased levels of mRNA for HMG-CoA reduc-
tase. This view contrasts with that of Ness, Keller, and
Pendleton (28) as stated in the title of their paper “Feed-
back regulation of hepatic 3-hydroxy-3-methylglutaryl-CoA
reductase activity by dietary cholesterol is not due to al-
tered mRNA levels.” These authors utilized a 14-h light/
10-h dark daily cycle, and obtained samples at or just past
the midpoint of the dark cycle (roughly equivalent to our
midnight time-point). The discrepancy may arise because
Ness et al. (28) selected a single time-point during the day
for study, possibly so far into the dark cycle that, although
near the peak of cholesterol synthesis, mRNA levels had
already returned to near-normal levels (see Figs. 1A and
B). As indicated in Fig. 1B, missing the approximately 8-h
period of markedly elevated mRNA levels would give a re-
sult suggesting that mRNA levels do not vary much as a
function of diet. Our study does not challenge the several
papers from this group (e.g., 29) indicating that both di-
urnal variation and cholesterol feeding status bring about
changes in the amount of HMG-CoA reductase as immu-
noreactive protein; rather it suggests a different (or addi-
tional) control point for effecting this change.
Our conclusions may also restrict somewhat the gener-
alization of Spady and Cuthbert (30) who state that “in
vivo cholesterol synthesis is predominantly controlled by
postranscriptional regulation of HMG-CoA reductase ac-
tivity.” Their relevant data demonstrated that levels of he-
patic HMG-CoA reductase mRNA were reduced by only
50% while total cholesterol synthesis was suppressed by
98% by feeding of high levels of bile salts as well as choles-
terol. We assume that this more vigorous manipulation
and the greater age of the animals they studied (about 4
months old) might present a more extreme case in which
compensatory mechanisms available at the level of tran-
scription are exceeded and other mechanisms, noted in
the Introduction, come into play.
Our study also adds to what is known regarding regula-
tion of LDL-R mRNA levels. In cultured cells, regulation
of steady-state mRNA levels for LDL-R correlate well with
those for HMG-CoA reductase (31). The correlation is
weaker in vivo in the mouse, where a diet-induced 10-fold
increase in hepatic mRNA for HMG-CoA reductase pro-
duced only a 2-fold increase in mRNA for LDL-R (32).
Our results for the rat also indicate that, under normal
circumstances, the correlation is weak (our data cannot
exclude a 10 to 2 correlation). Again, if the regulatory
mechanism is more severely strained, as with bile salt feed-
ing, a coordinate regulation of mRNA for these two genes
in vivo can be demonstrated (30).
Results for brain were very different from those ob-
tained with liver. These experiments, the initial focus of
the present study, were to determine whether synthesis
of cholesterol by brain was subject to diurnal variation.
Were this the case, it would complicate our ongoing studies
of coordination of metabolic events involved in regenera-
tion of myelin, a cholesterol-enriched membrane, after
metabolic insult. The negative result for diurnal variation
in brain also serves as a control for the positive results ob-
tained with liver.
The data for adrenal gland also show a 4-fold diurnal
variation in accumulation of newly synthesized choles-
terol, of about the same magnitude and time-course as in
liver. This is as expected from the well-known diurnal
rhythm of HMG-CoA reductase enzyme activity shown in
the adrenal gland of the rat (33, 34). Our data suggest
that, unlike the situation in the liver, the control for this
cycle is not at the level of a proportional increase in level
of mRNA for HMG-CoA reductase. This is not unexpected
in view of the demonstration that the steady-state level of
the mRNA is higher than that achieved by liver at any time
during the diurnal cycle. We note that our observation of
lack of diurnal cycle for this mRNA species is not com-
pletely compatible with a previous investigation (34) in
which a 2-fold variation of mRNA levels for this enzyme
was demonstrated.
Another interpretation of the data is that much of the
labeled cholesterol accumulating in adrenal glands may
be of hepatic origin and may arrive through the circula-
tion. It is known that the adrenal glands obtain apprecia-
ble amounts of newly synthesized cholesterol from the cir-
culation (35, 36). The scavenger receptor SR-B1 has been
reported to play a prominent role in delivering choles-
terol from the circulation to adrenal gland, where its ex-
pression is coordinately regulated with steroidogenesis
(22, 37–39). In fact, steady-state mRNA levels for this re-
ceptor were much higher in adrenal than in either liver or
brain. The moderate increase in SR-B1 mRNA levels dur-
ing the dark feeding period supports a role for this recep-
tor in uptake of cholesterol by the adrenal, regardless of
the dietary state.
In summary, our data suggest that alteration of steady-
state levels of mRNA for HMG-CoA reductase can account
for diurnal variation in hepatic cholesterol synthesis. Fur-
thermore, we have shown that, contrary to expectations
from the literature, basal levels of mRNA coding for HMG-
CoA reductase in liver are altered by cholesterol feeding.
Fig. 4. Relative levels of mRNA expression for HMG-CoA reduc-
tase, LDL-R, and SR-B1 in liver, brain, and adrenal gland. Data
shown are from tissues taken from animals on a low-cholesterol
diet, at the 4 pm time-point (maximal level of mRNA for HMG-CoA
reductase in liver). Data were normalized to a constant amount of
rRNA in each sample and are plotted relative to maximal values for
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